Direct inhibition of rat detrusor muscle contraction by erythromycin

Neurourology and Urodynamics

Volumn 23, Issue 3, 2004, Pages 273-279

  England, Roland C D ^a   Norman, Robert I ^b   Elliott, Ruth A ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Contraction; Detrusor; Erythromycin; Inhibition; Smooth muscle

Indexed keywords

ATROPINE; CARBACHOL; ERYTHROMYCIN; NIFEDIPINE; POTASSIUM; ADENOSINE TRIPHOSPHATE; ALCOHOL; ANTIINFECTIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL DEPRESSANT AGENT; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER MUSCLE; CONTROLLED STUDY; DETRUSOR MUSCLE; ELECTROSTIMULATION; MUSCLE CONTRACTION; NONHUMAN; RAT; ANIMAL; BLADDER; CALCIUM SIGNALING; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY; SMOOTH MUSCLE; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-BACTERIAL AGENTS; ATROPINE; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CARBACHOL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ERYTHROMYCIN; ETHANOL; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NIFEDIPINE; POTASSIUM; RATS; RATS, WISTAR; URINARY BLADDER;

EID: 2542429364     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.20019     Document Type: Article

References (20)

1. Appell RA, Sand P, Dmochowski R, et al. 2001. Prospective randomized controlled trial of extended-release oxybutinin chloride and tolteridine tartrate in the treatment of the overactive bladder: Results of the Object Study. Mayo Clin Proc 76:358-63.
2. Armstrong D, Ballantyne G, Modlin I. 1992. Erythromycin stimulates ileal motility by activation of dihydropyridine-sensitive calcium channels. J Surg Res 52:140-6.
3. Brading A, Williams J. 1990. Contractile responses of smooth muscle strips from rat and guinea-pig urinary bladder to transmural stimulation: Effects of atropine and α,β-methylene ATP. Br J Pharmacol 99:493-8.
4. Depoortere I, Peeters T. 1997. Inhibitory effects of motilides at high concentration are not mediated via motilin receptors, but by calcium channels. Gastroenterology 112:A721.
5. Latifpour J, Yoshida M, Weiss RM. 1992. Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 345:679-87.
6. Liberman JN, Hunt TL, Stewart WF, et al. 2001. Health-related quality of life among adults with symptoms of overactive bladder: Results from a US community-based survey. Urology 57:1044-50.
7. Maggi CA, Giuliani S, Patacchini R, et al. 1998. Multiple sources of calcium for contraction of the human urinary bladder muscle. Br J Pharmacol 98:1021-31.
8. Mannisto P, Tuomisto J, Rasanen R. 1975. Absorption of erythromycin. A cross-over study in healthy volunteers. Arzneimittelforschung 25:1828-31.
9. Messelink EJ. 1999. Treatment of overactive bladder with tolterodine: A new muscarinic receptor antagonist. BJU Int 83:48-52.
10. Milsom I, Stewart W, Thüroff J. 2000. The prevalence of overactive bladder symptoms. Am J Manag Care 6:S565-73.
11. Minocha A, Galligan J. 1991. Erythromycin inhibits contractions of nerve-muscle preparations of the guinea-pig small intestine. J Pharmacol Exp Ther 257:1248-52.
12. Nissan A, Mashriki Y, Zhang J, et al. 1997. Direct effect of erythromycin on the gallbladder muscle. J Gastrointest Surg 1:331-6.
13. Nissan A, Maudlej N, Beglaibter N, et al. 1999. A direct inhibitory effect of erythromycin on rat urinary bladder smooth muscle. J Urol 161:1006-9.
14. Peeters T, Matthijs G, Depoortere I, et al. 1989. Erythromycin is a motilin receptor agonist. Am J Physiol 257:G470-4.
15. Sibley G. 1984. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig, and rabbit. J Physiol 354:431-43.
16. Tamaoki J, Tagaya E, Sakai A, et al. 1995. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol 95:853-9.
17. Van Kerrebroeck P, Kreder K, Jonas U, et al. 2001. Tolteridine once daily: Superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414-21.
18. Wagner TH, Hu T-W. 1998. Economic costs of urinary incontinence in 1995. Urology 51:355-61.
19. Wu C, Bayliss M, Newgreen D, et al. 1999. A quantitative study of atropine-resistant contractile response in human detrusor smooth muscle, from stable, unstable, and obstructed bladders. J Urol 162:1833-9.
20. Zara G, Thompson H, Pilot M, et al. 1985. Effects of erythromycin on gastrointestinal motility. J Antimicrob Chemother 16:175-9.